Proficio Capital Partners LLC purchased a new position in Azenta, Inc. (NASDAQ:AZTA - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 18,200 shares of the company's stock, valued at approximately $910,000.
A number of other hedge funds also recently bought and sold shares of AZTA. Farther Finance Advisors LLC lifted its stake in Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock valued at $74,000 after acquiring an additional 256 shares during the period. KBC Group NV increased its position in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after purchasing an additional 698 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in shares of Azenta during the 4th quarter valued at about $200,000. Aigen Investment Management LP purchased a new stake in shares of Azenta during the 3rd quarter valued at about $214,000. Finally, Empowered Funds LLC purchased a new stake in shares of Azenta during the 4th quarter valued at about $293,000. Institutional investors own 99.08% of the company's stock.
Azenta stock traded up $2.57 during midday trading on Friday, hitting $43.68. The stock had a trading volume of 810,259 shares, compared to its average volume of 579,068. Azenta, Inc. has a 52-week low of $38.82 and a 52-week high of $65.51. The company has a market capitalization of $2.00 billion, a PE ratio of -14.66 and a beta of 1.52. The firm's fifty day moving average is $49.26 and its two-hundred day moving average is $47.39.
Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, equities research analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.
Several equities research analysts have recently commented on the stock. Needham & Company LLC upped their price target on shares of Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research report on Thursday, February 6th. Stephens reaffirmed an "overweight" rating and set a $60.00 price target on shares of Azenta in a research report on Thursday, January 2nd. Evercore ISI upped their price target on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research report on Thursday, February 6th. Finally, TD Cowen raised shares of Azenta to a "hold" rating in a report on Thursday, February 27th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $58.75.
View Our Latest Research Report on Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.